2m 2m 2m 2m 2m 2m 2m
Zoetis-A (ZTS)
NYSE
$77.40+$0.10 (+0.14%)
Price as of Jul 31, 2026 7:55 PM EDT- $31.9BMarket Cap
- -46.55%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Zoetis-A (ZTS)
$77.40+$0.10 (+0.14%)
ZTS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $77.29 | ||
Change | +$1.26 (+1.66%) | ||
Open | $75.61 | ||
High | $77.52 | ||
Low | $74.91 | ||
Previous Close | $76.03 | ||
Volume | 5,018,256 | ||
30-Day Average Volume | 5,519,198 | ||
1-Week Change | 2.57% | ||
1-Month Change | 8.31% | ||
1-Year Change | -46.55% | ||
3-Year Change | -57.19% | ||
5-Year Change | -59.67% | ||
Fundamentals | |||
Shares Outstanding | 419.2M | ||
Total Assets | $15.2B | ||
Market Cap | $31.9B | ||
Enterprise Value | $39.0B | ||
Period: QTR TTM FY | |||
Revenue | $2.3B | ||
Net Income | $601.0M | ||
Free Cash Flow | $291.0M | ||
EBIT | $820.0M | ||
EBITDA | $939.0M | ||
Net Working Capital | $4.4B | ||
EPS | $1.42 | ||
Enterprise Value/EBITDA | 42 | ||
Enterprise Value/Revenue | 17 | ||
P/B | 10 | ||
P/E | 54 | ||
PEG | 16 | ||
Price/Free Cash Flow | 111 | ||
Price/Operating Cash Flow | 81 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.74% | ||
Trailing Annual Dividend Yield | 2.70% | ||
Ex-Dividend Date | 07/20/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield